Share

Networks

Clinical Studies (2)

  • Perrotta : Study aims to evaluate the impact of SARS-CoV-2 vaccination on virological clearance, COVID-19 related hospitalization, ICU admission, and 30-day mortality in SARS-CoV-2 infected patients receiving monoclonal antibodies due to their risk for COVID-19 progression
  • mpox-ICONA : Study aims to assess mpox disease, which recognises an epidemiological network that overlaps with HIV. To identify predictors of severe evolution and disease duration in mpox cases, as well as to test the association between mpox severity and viral load in biological fluids

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • People at high risk of STIs
  • People living with HIV
  • Hospital
  • Emergency department
  • Infectious diseases unit
  • SARS-CoV-2
  • Monkeypox virus
  • Acute COVID-19
  • Mpox
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • Bamlanivimab/ Etesevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to